Cargando…

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density

BACKGROUND: To develop a customized prostate biopsy indication using prostate health index density (PHID) combined with multiparametric magnetic resonance imaging (mpMRI) and assess the reliability of the PHID cutoff value in external populations. METHODS: A total of 521 cognitive MRI/ultrasonograph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Yeon, Jeon, Seong Soo, Chung, Jae Hoon, Lee, Seung Soo, Park, Sung-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513902/ https://www.ncbi.nlm.nih.gov/pubmed/37745905 http://dx.doi.org/10.1016/j.prnil.2023.07.001

Ejemplares similares

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
por: Ryoo, Hyunsoo, et al.
Publicado: (2020)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
por: Lee, Chung Un, et al.
Publicado: (2021)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
por: Yu, Jiwoong, et al.
Publicado: (2021)

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020)

Prospective Analysis on the Relation between Pain and Prostate Volume during Transrectal Prostate Biopsy
por: Yun, Tae Jin, et al.
Publicado: (2007)

External validation of extended prostate biopsy nomogram
por: Hrbáček, Jan, et al.
Publicado: (2015)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate
por: Kim, Sang Jin, et al.
Publicado: (2010)

Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 Lesions
por: Lee, Chung-Un, et al.
Publicado: (2022)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Paradigm Shift in Prostate Cancer Diagnosis: Pre-Biopsy Prostate Magnetic Resonance Imaging and Targeted Biopsy
por: Park, Jung Jae, et al.
Publicado: (2022)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
por: Kim, Dong-Soo, et al.
Publicado: (2021)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Biopsy interpretation of the prostate
por: Epstein, Jonathan I.

Prostate biopsy interpretation
por: Epstein, Jonathan I.

What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
por: Sonmez, Gokhan, et al.
Publicado: (2020)

Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging
por: Lee, Chung Un, et al.
Publicado: (2022)

The meaning of sampling density in multiple repeat prostate biopsies
por: Hrbáček, Jan, et al.
Publicado: (2016)

The use of prostate MR for targeting prostate biopsies
por: Kelley, R. Phelps, et al.
Publicado: (2019)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy
por: Truong, Matthew, et al.
Publicado: (2017)

Can Western Based Online Prostate Cancer Risk Calculators Be Used to Predict Prostate Cancer after Prostate Biopsy for the Korean Population?
por: Lee, Dong Hoon, et al.
Publicado: (2013)

Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019)

A review of optimal prostate biopsy: indications and techniques
por: Streicher, Justin, et al.
Publicado: (2019)

Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy
por: Bang, Jun-Ho, et al.
Publicado: (2013)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong
por: Bouttell, Janet, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
por: Song, Byeongdo, et al.
Publicado: (2022)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8pnq2bp9dgdp20tlf23h25fff8